Healthcare utilisation and associated costs for methadone versus buprenorphine recipients: Examination of interlinked primary and secondary care electronic health records in England
Differences in healthcare utilisation frequency for methadone versus buprenorphine recipients were observed. The differences in associated costs were mainly driven by hospital admissions. These findings offer valuable insights for optimising care strategies and resource allocation for OAT recipients.
Authors
- Eleni Domzaridou (ORCID: https://orcid.org/0000-0002-0096-1288)
- Darren Mark Ashcroft (ORCID: https://orcid.org/0000-0002-2958-915X)
- Matthew Carr (ORCID: https://orcid.org/0000-0001-7336-1606)
- Roger T. Webb (ORCID: https://orcid.org/0000-0001-8532-2647)
- Tim Millar (ORCID: https://orcid.org/0000-0003-4630-2357)
- Thomas Allen (ORCID: https://orcid.org/0000-0002-2972-7911)
Institutions
- University of Southern Denmark (DK)
- Manchester Academic Health Science Centre (GB)
- University of Manchester (GB)
- Centre for Mental Health (GB)
- National Institute for Health and Care Research (GB)
Publication Details
- Journal
- Drug and Alcohol Review
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1111/dar.13933
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- Department of Health and Social Care
- Manchester Biomedical Research Centre